跳至主要内容
临床试验/CTRI/2025/08/092380
CTRI/2025/08/092380尚未招募2/3 期

Comparison of Sugammadex and Neostigmine combination versus Sugammadex for reversal of vecuronium induced neuromuscular blockade in overweight patients- Randomised Control Study

Vinayaka Missions Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年8月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
To compare effectiveness of sugammadex with neostigmine and sugammadex for reversal of vecuronium induced neuromuscular blockade in patients with BMI more than 25 kg per metre square by using 90 percentage TOF ratio

研究概览

简要总结

This randomized controlled trial aims to compare the efficacy and safety of a half-dose sugammadex combined with neostigmine versus full-dose sugammadex alone for reversing vecuronium-induced deep neuromuscular blockade in patients with BMI > 25kg/m² undergoing elective surgeries under general anesthesia. The study addresses both clinical outcomes and economic considerations, given the high cost and potential adverse effects of sugammadex at full doses. The primary endpoint is the time to disappearance of fade in Double Burst Stimulation (DBS), with secondary endpoints including adverse effects, extubation time, cost-effectiveness, and hemodynamic changes. Ninety patients will be enrolled in a double-blinded, randomized design at a tertiary care hospital. This study hopes to establish a safer, faster, and more cost-effective reversal strategy in overweight and obese patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • BMI more than 25 kg per metre square 2) Undergoing elective surgery and requiring the use of muscle relaxants throughout the surgery.
  • ASA physical status 1 to 3.

排除标准

  • Presence of renal dysfunction defined as creatinine more than 1.2 mg per dl 2) Known hepatic disease 3) Obstructive sleep apnea 4) Allergic to general anaesthesia drugs 5) History of substance abuse.
  • Altered mental status.
  • Patients receiving medications known to interfere with neuromuscular transmission or having neuromuscular disease.

结局指标

主要结局

To compare effectiveness of sugammadex with neostigmine and sugammadex for reversal of vecuronium induced neuromuscular blockade in patients with BMI more than 25 kg per metre square by using 90 percentage TOF ratio

时间窗: 1 min, 5mins, 10mins, 15 mins,30 mins

次要结局

  • incidence of adverse events less in combined half dose of sugammadex & neostigmine & to find which is cost effective(within 24 hours post surgery)

研究者

发起方
Vinayaka Missions Medical College and Hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Prasanna Vadhanan

Vinayaka Missions Medical College and Hospital, Karaikal

研究点 (1)

Loading locations...

相似试验

Comparing Sugammadex Alone to a Combination of... | 临床试验